Literature DB >> 7591646

Inhibition of lens opacification during the early stages of cataract formation.

T Hiraoka1, J I Clark.   

Abstract

PURPOSE: To characterize the time period during cataract formation in which administration of pantethine inhibits lens cell opacification in the selenite model for cataract.
METHODS: Pantethine was administered to neonatal rat pups at selected time points from -0.5 to 17 hours with respect to injection of selenite at time = 0. The injection dose of pantethine was 820 mg/kg (1.5 mmol/kg) diluted in water at 410 mg/ml concentration. The injection dose of selenite was 3.28 mg/kg (19 mumol/kg) diluted in saline at 1.8 mg/ml concentration. Opacification was observed using a slit lamp microscope at selected time points over a 14-day period. Cataracts were staged using a classification of opacity from 0 (normal) to 6 (mature).
RESULTS: The effect of pantethine was characterized by three different time periods: administration -0.5 to 6 hours with respect to selenite injection provided highly significant protection, P < 0.001; administration 8 hours after selenite provided significant protection, P < 0.005; administration 10 to 17 hours after selenite was not protective.
CONCLUSIONS: The metabolite pantethine inhibited lens opacification during cataract formation in the selenite model. Even when pantethine was injected several hours after the administration of selenite, opacification was inhibited. Advanced stages of opacification were unresponsive to the administration of pantethine. The inhibitory effect of pantethine was statistically significant when administered during the earliest stage of opacification in the selenite model for cataract.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7591646

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  17 in total

1.  Modulation of the chaperone-like activity of bovine alpha-crystallin.

Authors:  J I Clark; Q L Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

2.  Comparison of the impact of epigallocatechin gallate and ellagic acid in an experimental cataract model induced by sodium selenite.

Authors:  Irfan Ergen; Burak Turgut; Nevin Ilhan
Journal:  Int J Ophthalmol       Date:  2017-04-18       Impact factor: 1.779

3.  Rutin ameliorates free radical mediated cataract by enhancing the chaperone activity of α-crystallin.

Authors:  V Sasikala; B N Rooban; V Sahasranamam; Annie Abraham
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-02-15       Impact factor: 3.117

Review 4.  Can drugs or micronutrients prevent cataract?

Authors:  J J Harding
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

5.  Self-assembly of protein aggregates in ageing disorders: the lens and cataract model.

Authors:  John I Clark
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-03-25       Impact factor: 6.237

6.  Noninvasive measurement of protein aggregation by mutant huntingtin fragments or alpha-synuclein in the lens.

Authors:  Paul J Muchowski; Richard Ramsden; QuangVu Nguyen; Ernest E Arnett; Teri M Greiling; Susan K Anderson; John I Clark
Journal:  J Biol Chem       Date:  2007-12-31       Impact factor: 5.157

7.  Inhibitory effects of grape seed proanthocyanidin extract on selenite-induced cataract formation and possible mechanism.

Authors:  Xuan Zhang; Yizhen Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-08-11

8.  Clinical detection of precataractous lens protein changes using dynamic light scattering.

Authors:  Manuel B Datiles; Rafat R Ansari; Kwang I Suh; Susan Vitale; George F Reed; J Samuel Zigler; Frederick L Ferris
Journal:  Arch Ophthalmol       Date:  2008-12

9.  Hydrogen saline prevents selenite-induced cataract in rats.

Authors:  Chun-xiao Yang; Hong Yan; Tian-bing Ding
Journal:  Mol Vis       Date:  2013-07-29       Impact factor: 2.367

10.  Hesperetin prevents selenite-induced cataract in rats.

Authors:  Yosuke Nakazawa; Mikako Oka; Masayasu Bando; Makoto Takehana
Journal:  Mol Vis       Date:  2015-07-31       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.